<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491165</url>
  </required_header>
  <id_info>
    <org_study_id>2011-12-07 liver cirrhosis</org_study_id>
    <nct_id>NCT01491165</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis</brief_title>
  <official_title>Safety and Efficacy of Umbilical Cord Mesenchyma Stem Cell Transplantation in Liver Cirrhosis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Chinese Armed Police Forces</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xinjiang Armed Police Corps Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taian Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>General Hospital of Chinese Armed Police Forces</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mainstream of current treatment of liver cirrhosis is liver transplantation, but there are
      high cost, risk and immune rejection and other issues. Umbilical cord mesenchyma stem cell
      with self-and directed differentiation capacity can effectively rescue experimental liver
      failure and contribute to liver regeneration, which suggests the feasibility of stem cell
      transplantation therapy. In this study, the safety and efficacy of umbilical cord mesenchyma
      stem cell transplantation through interventional procedures in patients liver cirrhosis will
      be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study included three research centers, each center were carried out 25 cases of liver
      cirrhosis in patients with stem cell transplantation. All the selection and exclusion
      criteria are same, data summary and analysis will be complete by the epidemiological
      commissioner.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>liver volume calculated by MRI</measure>
    <time_frame>3 days before transplantation, 6 and 12 months after transplantation</time_frame>
    <description>Instrument:universal 1.5 Tesla superconducting MRI instrument. Slice thickness :2mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>liver biopsy</measure>
    <time_frame>whinin 7 days before transplantation, 6 and 12 months after transplantation</time_frame>
    <description>The result of liver biopsy judged by the expert.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gastroscopy</measure>
    <time_frame>whinin 7 days before transplantation, 6 and 12 months after transplantation</time_frame>
    <description>Observe and photograph the related varicose veins.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood biochemistry</measure>
    <time_frame>whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation</time_frame>
    <description>alanine aminotransferase
aspartate aminotransferase
gamma-glutamyltransferase(GGT)
alkaline phosphatase
total bilirubin
direct bilirubin
The total bile acid (TBA)
serum cholinesterase (CHE)
total cholesterol (TC)
albumin
the proportion of white balls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood test</measure>
    <time_frame>whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation</time_frame>
    <description>platelet count (PLT)
mean platelet volume (MPV)
platelet distribution width (PDW)
platelet hematocrit (PCT)
alpha feto protein(AFP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>liver enzyme fiber spectrum</measure>
    <time_frame>whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation</time_frame>
    <description>laminin (LN)
Ⅳ collagen detection (CIV)
hyaluronic acid (HA)
procollagen Ⅲ(PC Ⅲ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>coagulation</measure>
    <time_frame>whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation</time_frame>
    <description>prothrombin time (PT)
activated partial thromboplastin time (APTT)
fibrinogen (FIB)
thrombin time (TT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>portal vein and splenic vein measure</measure>
    <time_frame>whinin 7 days before transplantation, 1,3,6 and 12 months after transplantation</time_frame>
    <description>Portal vein diameter (Dpv);
Portal vein maximum velocity (Vmaxpv);
Portal vein blood flow per minute (Qpv);
The splenic vein diameter (Dsv);
Splenic vein maximum flow velocity (Vmaxsv);
Splenic vein blood flow per minute (Qsv).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Other Surgical Procedures</condition>
  <arm_group>
    <arm_group_label>stem cell transplantation therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>umbilical cord mesenchyma stem cell transplantation through interventional procedures do in liver cirrhosis patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>stem cell transplantation through interventional procedures</intervention_name>
    <description>one time interventional procedures</description>
    <arm_group_label>stem cell transplantation therapy</arm_group_label>
    <other_name>umbilical cord mesenchyma stem cell transplantation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of liver cirrhosis;

          -  Without hepatic encephalopathy;

          -  No ascites or have easily dissipated ascites;

          -  Value of bilirubin is less than 100;

          -  Value of albumin is greater than 16 g / L;

          -  Prothrombin time is less than 21 seconds;

        Exclusion Criteria:

          -  Severe cardiovascular disease, and immunocompromised patients;

          -  Patients with localized lesions affecting graft infection;

          -  Coagulation disorders;

          -  Liver nodules more than 2cm or Liver cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yihua An</last_name>
    <role>Study Director</role>
    <affiliation>Department of Stem Cell Transplantation, the General Hospital of Chinese People's Armed Police Force</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yihua An</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yihua An, doctor</last_name>
      <phone>0086-10-88276848</phone>
      <email>doctoran2010@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2011</study_first_submitted>
  <study_first_submitted_qc>December 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2011</study_first_posted>
  <last_update_submitted>October 25, 2012</last_update_submitted>
  <last_update_submitted_qc>October 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>umbilical cord mesenchyma stem cell</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

